申请人:Cianci Christopher W.
公开号:US08362004B2
公开(公告)日:2013-01-29
A compound of Formula I is set forth, including pharmaceutically acceptable salts thereof:
wherein Het is a 5 or 6-membered heterocycle with —N, —O, or —S adjacent to the —Ar substituent or adjacent to the point of attachment for the —Ar substituent;
Ar is aryl or heteroaryl;
R is —CH3, —CH2F, or —CH═CH2;
W is —NO2, —Cl, —Br, —CHO, —CH═CH2, or —CN;
X is —Cl, —CH3, or —CN;
Y is —CH or —N; and
Z is C1-C6 alkyl, C3-C6 cycloalkyl, substituted aryl, substituted heteroaryl, OR1, or NHR1, wherein R1 is selected from the group of H, aryl, heteroaryl, C1-C6 alkyl and C3-C6 cycloalkyl.
This compound is useful in compositions for the prevention and treatment of influenza virus.
公式I的化合物及其药用可接受的盐被描述如下:其中Het是一个5或6元杂环,其与—Ar取代基相邻或与—Ar取代基的连接点相邻的位置上有—N、—O或—S;Ar是芳基或杂芳基;R是—
CH3、—
CH2F或—CH═
CH2;W是—
NO2、—Cl、—Br、—CHO、—CH═ 或—CN;X是—Cl、— 或—CN;Y是—CH或—N;而Z是C1-C6烷基、C3-C6环烷基、取代芳基、取代杂芳基、OR1或NHR1,其中R1选自H、芳基、杂芳基、C1-C6烷基和C3-C6环烷基的群。该化合物可用于预防和治疗流感病毒的组合物中。